For over two decades, our formulations have leveraged the unique regenerative power of copper-binding tripeptides to address aging, photodamage, and compromised barrier function at the cellular level
The Food and Drug Administrations own prescribing label already notes that semaglutide is not recommended in patients with severe gastroparesis, meaning that the agency acknowledges the risk
Too bad the finish decided to circle back to the beginning, and end things with more of those fruits that had gone off, and that wet cardboard, tied in a bow with olives and brine
Theres no evidence that GLP-1 medications increase seizure risk in most people with epilepsy, and there may be some benefit
What patients want to know is what it costs, how it is administered, and what a realistic timeline looks like
10.3389/fendo.2023.1085799